Category Archives: Hepatology: Hepatitis C

The dangerous pathogens lurking in urban rats

In the first study to look at would-be diseases carried by New York City rats, scientists at the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health identified bacterial pathogens, including E. coli, Salmonella, and C. … Continue reading

Posted in Environmental Health: Rats, Environmental Health: Urban, Hepatology: Hepatitis C, Infectious Diseases: Clostridium Difficile, Infectious Diseases: Seoul Hantavirus, Nutrition: Salmonella | Leave a comment

FDA approves first combination pill to treat hepatitis C

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection. It is also the … Continue reading

Posted in Hepatology: Hepatitis C | Leave a comment

The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users

J Theor Biol. 2013 Sep 21;333:126-34. doi: 10.1016/j.jtbi.2013.05.017. Epub 2013 Jun 1. The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users. De Vos AS, Kretzschmar ME. Source: Julius Center, University … Continue reading

Posted in Hepatology: Hepatitis C, HIV | Comments Off

Tats and Hep C: a new study shows linkage

Association of tattooing and hepatitis C virus infection: A multicenter case-control study Kerrilynn Carney, et. al.   Hepatology DOI: 10.1002/hep.26245 Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in … Continue reading

Posted in Hepatology: Hepatitis C | Comments Off

Hep C drug warning

[12-19-2012] The U.S. Food and Drug Administration (FDA) received reports of serious skin reactions, some fatal, in patients taking the hepatitis C drug Incivek (telaprevir) in combination with the drugs peginterferon alfa and ribavirin (Incivek combination treatment).  Significantly, some patients … Continue reading

Posted in Hepatology: Hepatitis C | Comments Off

Telaprevir: Added benefit in certain patients with hepatitis C

Probability of added benefit varies / Extent of added benefit partly unclear / Also indications of greater harm The drug telaprevir (trade name: Incivo®) has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. … Continue reading

Posted in Hepatology: Hepatitis C | Comments Off

Hepatitis C cost burden update

The importance of early detection of hepatitis C infection is becoming increasingly important for physical and financial health. Henry Ford Hospital researchers found that health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher … Continue reading

Posted in Health Care: Costs, Hepatology: Hepatitis C | Comments Off

Curing Hepatitis C: a new book

Hepatitis C Doesn’t Have to Be a Lifelong Illness Curing Hepatitis C provides the latest information to guide you through the diagnosis and treatment of hepatitis C. If you or a loved one has been diagnosed with hepatitis C, this … Continue reading

Posted in Hepatology: Hepatitis C, HIV | Comments Off

For people who inject drugs, four ways to reduce hepatitis infections

WHO has identified four key actions countries can take to prevent viral hepatitis B and C among people who inject drugs. Of the estimated 16 million people who inject drugs worldwide, it is estimated that 10 million are infected with … Continue reading

Posted in Hepatology: Hepatitis B, Hepatology: Hepatitis C, HIV | Comments Off

Milk thistle does not help hep C patients: JAMA

JAMA. 2012 Jul 18;308(3):274-282. Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy: A Randomized Controlled Trial Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo … Continue reading

Posted in Alternative Medicine, Hepatology: Hepatitis C | 1 Comment

Hepatitis C: All baby boomers should be tested, says CDC

On the eve of the first ever National Hepatitis Testing Day (May 19), the Centers for Disease Control and Prevention is issuing draft guidelines proposing that all U.S. baby boomers get a one-time test for the hepatitis C virus. One … Continue reading

Posted in Hepatology: Hepatitis C | Comments Off

Viral hepatitis updates from CDC

More viral hepatitis posts May is Hepatitis Awareness Month During the month of May, CDC’s Division of Viral Hepatitis (DVH) will be observing Hepatitis Awareness Month and the first ever national Hepatitis Testing Day on May 19th. Buttons, badges, and banners … Continue reading

Posted in Hepatology, Hepatology: Hepatitis B, Hepatology: Hepatitis C, Hepatology: Hepatitis E | Comments Off

Broader hepatitis C screening would be cost effective, study suggests

Broader screening to identify people infected with hepatitis C virus (HCV) would likely be cost effective, according to a new report published in Clinical Infectious Diseases and available online (http://cid.oxfordjournals.org/content/early/2012/02/27/cid.cis011.abstract). Significantly reducing HCV-related mortality and morbidity, however, will require a … Continue reading

Posted in Hepatology: Hepatitis C | Comments Off